CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 71 filers reported holding CULLINAN ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $779,305 | -28.6% | 86,111 | -15.1% | 0.00% | – |
| Q2 2023 | $1,091,355 | -40.7% | 101,427 | -43.6% | 0.00% | – |
| Q1 2023 | $1,839,558 | +3.9% | 179,820 | +7.1% | 0.00% | – |
| Q4 2022 | $1,771,240 | -57.7% | 167,890 | -48.6% | 0.00% | -100.0% |
| Q3 2022 | $4,189,000 | +97.7% | 326,750 | +97.7% | 0.00% | – |
| Q2 2022 | $2,119,000 | +141.9% | 165,309 | +97.6% | 0.00% | – |
| Q1 2022 | $876,000 | -29.4% | 83,651 | +4.0% | 0.00% | – |
| Q4 2021 | $1,240,000 | -65.1% | 80,401 | -49.0% | 0.00% | -100.0% |
| Q3 2021 | $3,555,000 | +1017.9% | 157,501 | +1175.0% | 0.00% | – |
| Q2 2021 | $318,000 | -86.4% | 12,353 | -78.0% | 0.00% | -100.0% |
| Q1 2021 | $2,336,000 | – | 56,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $98,051,000 | 27.24% |
| CHI Advisors LLC | 3,047,609 | $39,070,000 | 14.92% |
| Nextech Invest Ltd. | 1,221,145 | $15,655,000 | 5.28% |
| BVF INC/IL | 7,509,059 | $96,266,000 | 4.65% |
| TANG CAPITAL MANAGEMENT LLC | 609,231 | $7,810,000 | 1.18% |
| Boxer Capital, LLC | 1,074,082 | $13,770,000 | 0.87% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 213,090 | $2,732,000 | 0.84% |
| Atom Investors LP | 96,880 | $1,242,000 | 0.54% |
| EcoR1 Capital, LLC | 1,169,889 | $14,998,000 | 0.52% |
| Birchview Capital, LP | 45,114 | $578,000 | 0.42% |